 |
Search
|
|
|
AVIAN SUSCEPTIBILITIES
1/97-1/98
| ANTIMICROBIC |
Bacillus spp.
|
Escherichia Coli
|
Enterobacter spp
|
Pseudamonas spp
|
Serratia spp
|
Salmonella spp
|
Staphylococcus auerus
|
Enterobacter spp
|
Klebsiella spp.
|
Pasteurella multocida
|
Proteus spp.
|
Pseudamonas spp
|
| |
NUMBER %S
|
NUMBER %S
|
NUMBER %S
|
NUMBER %S
|
NUMBER %S
|
NUMBER %S
|
NUMBER %S
|
NUMBER %S
|
NUMBER %S
|
NUMBER %S
|
NUMBER %S
|
NUMBER %S
|
| Amikacin |
14 100
|
7 100
|
4 100
|
5 100
|
3 100
|
6 100
|
5 100
|
14 100
|
14 100
|
7 100
|
4 100
|
5 100
|
| Amoxic/Cluv |
11 100
|
7 100
|
3 67
|
3 0
|
3 33
|
4 100
|
4 100
|
13 38
|
11 100
|
7 100
|
3 67
|
3 0
|
| Ampicillin |
14 0
|
7 100
|
4 75
|
5 20
|
3 33
|
6 100
|
5 60
|
14 36
|
14 0
|
7 100
|
4 75
|
5 20
|
| Apramycin |
5 60
|
1 0
|
1 100
|
3 100
|
1 100
|
6 100
|
4 100
|
3 67
|
5 60
|
1 0
|
1 100
|
3 100
|
| *Ceftiofur |
12 100
|
7 86
|
4 100
|
5 20
|
3 67
|
6 100
|
5 100
|
14 71
|
12 100
|
7 86
|
4 100
|
5 20
|
| Cephalothin |
14 86
|
7 86
|
4 100
|
5 0
|
3 0
|
6 100
|
5 100
|
14 29
|
14 86
|
7 86
|
4 100
|
5 0
|
| Clindamycin |
13 0
|
6 50
|
4 0
|
4 0
|
2 0
|
2 0
|
2 100
|
13 0
|
13 0
|
6 50
|
4 0
|
4 0
|
| *Enrofloxacin |
7 100
|
5 100
|
2 50
|
3 100
|
1 100
|
18 94
|
21 48
|
3 100
|
7 100
|
5 100
|
2 50
|
3 100
|
| *Erythromycin |
14 0
|
7 57
|
5 0
|
5 0
|
3 0
|
18 0
|
21 52
|
14 0
|
14 0
|
7 57
|
5 0
|
5 0
|
| Florfenicol |
3 0
|
7 100
|
1 0
|
2 0
|
3 100
|
2 0
|
1 0
|
1 0
|
3 0
|
7 100
|
1 0
|
2 0
|
| *Gentamicin |
14 93
|
1 0
|
5 60
|
5 100
|
1 0
|
18 83
|
21 24
|
14 100
|
14 93
|
1 0
|
5 60
|
5 100
|
| Lincomycin |
1 0
|
1 100
|
1 100
|
1 0
|
1 100
|
4 0
|
3 33
|
1 0
|
1 0
|
1 100
|
1 100
|
1 0
|
| Neomycin |
5 80
|
1 100
|
1 0
|
3 100
|
1 0
|
6 100
|
4 100
|
3 100
|
5 80
|
1 100
|
1 0
|
3 100
|
| Novobiocin |
5 20
|
7 71
|
4 0
|
3 0
|
3 0
|
6 0
|
4 100
|
3 0
|
5 20
|
7 71
|
4 0
|
3 0
|
| Oxacillin |
14 0
|
7 86
|
5 40
|
5 0
|
3 0
|
6 0
|
5 100
|
14 0
|
14 0
|
7 86
|
5 40
|
5 0
|
| *Penicillinff |
14 0
|
1 100
|
2 50
|
5 0
|
1 100
|
18 22
|
21 52
|
14 0
|
14 0
|
1 100
|
2 50
|
5 0
|
| *Sarafloxacin |
3 67
|
1 0
|
1 0
|
2 50
|
1 0
|
14 93
|
17 35
|
1 100
|
3 67
|
1 0
|
1 0
|
2 50
|
| *Sulfadi/Trime |
2 0
|
1 100
|
2 50
|
1 0
|
1 100
|
4 0
|
3 33
|
2 0
|
2 0
|
1 100
|
2 50
|
1 0
|
| *Spectinomycin |
5 40
|
7 86
|
5 0
|
3 33
|
3 67
|
6 33
|
4 0
|
3 33
|
5 40
|
7 86
|
5 0
|
3 33
|
| Sulfachlorpyr |
5 80
|
1 100
|
1 0
|
3 67
|
1 0
|
18 44
|
20 80
|
3 67
|
5 80
|
1 100
|
1 0
|
3 67
|
| *Tetracycline |
14 57
|
1 100
|
4 25
|
5 40
|
1 0
|
18 61
|
21 24
|
14 93
|
14 57
|
1 100
|
4 25
|
5 40
|
| Tiamulin |
5 20
|
7 86
|
3 0
|
3 67
|
6 17
|
4 100
|
3 0
|
5 20
|
7 86
|
1 0
|
3 0
| |
| Tilmicosin |
3 0
|
|
2 0
|
1 0
|
6 0
|
4 100
|
2 0
|
3 0
|
1 0
|
|
2 0
| |
| Tribuissin |
14 86
|
|
|
5 40
|
|
6 33
|
5 60
|
14 93
|
14 86
|
|
|
5 40
|
| Tylosin |
5 0
|
|
|
3 0
|
|
6 0
|
4 100
|
3 0
|
5 0
|
|
|
3 0
|
* Compounds listed in Table 1 (Suggested Groupings of Therapeutic
Antimicrobial Agents for Systemic Use) of the NCCLS M31T document.
These are used for therapeutic treatment of animal diseases. Other
compounds with prophyactic, control or prevention indications are
not listed except for poultry.
*a US-FDA approved.
*b US-FDA not approved but are frequently used in an
extra-label manner in the indicated animal.
- Prepared by the Bacteriology Laboratory - ADDL - Purdue
University.
|
|
April 26, 2025
|
|
